Rigel Pharmaceuticals
RIGL
#6832
Rank
NZ$0.78 B
Marketcap
$44.55
Share price
3.77%
Change (1 day)
199.68%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2023 (TTM): -$0.37

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.38. In 2022 the company made an earnings per share (EPS) of -$0.58 a decrease over its 2021 EPS that were of -$0.17.

EPS history for Rigel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.37-36.64%
2022-$0.58240%
2021-$0.17-37.5%
2020-$0.27-60%
2019-$0.69-11.11%
2018-$0.77-26.23%
2017-$1.05-17.57%
2016-$1.2725.42%
2015-$1.01-42.72%
2014-$1.771.98%
2013-$1.73-24.06%
2012-$2.28-4.32%
2011-$2.38-290.41%
2010$1.25-126.64%
2009-$4.70-25.14%
2008-$6.2841.86%
2007-$4.4270.86%
2006-$2.59-27.4%
2005-$3.57-33.33%
2004-$5.35-37.73%
2003-$8.59-31.83%
2002-$12.60-63.55%
2001-$34.57-96.43%
2000-$969.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.24 759.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.47 554.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.40-1,002.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
$24.26-6,531.82%๐Ÿ‡บ๐Ÿ‡ธ USA